Transplant Infectious Disease

Papers
(The H4-Index of Transplant Infectious Disease is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
95
53
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study53
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?53
48
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis41
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study39
Research Advice for Early Career Transplant Infectious Disease Clinicians35
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient33
Atypical pneumonia testing in transplant recipients31
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients29
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom29
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant27
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors27
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient27
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review25
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review25
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre25
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients23
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient23
Cytomegalovirus‐associated pseudomembranous colitis in a kidney transplant recipient21
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin21
Neuroinvasive West Nile virus infection in solid organ transplant recipients21
Vaccine protection and how we measure it21
0.85922193527222